# Pharmacokinetics of Besifovir in Adults With Normal and Impaired Renal Function

> **NCT04249908** · PHASE1 · UNKNOWN · sponsor: **IlDong Pharmaceutical Co Ltd** · enrollment: 40 (estimated)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** Besifovir Dipivoxil Maleate

## Key facts

- **NCT ID:** NCT04249908
- **Lead sponsor:** IlDong Pharmaceutical Co Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-13
- **Primary completion:** 2020-09
- **Final completion:** 2021-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04249908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04249908, "Pharmacokinetics of Besifovir in Adults With Normal and Impaired Renal Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04249908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*